Is antiphospholipid antibody determination clinically relevant to the vasculitides?

Seminars in Arthritis and Rheumatism

Volumn 31, Issue 1, 2001, Pages 1-3

  Cuchacovich, Raquel ^a   Espinoza, Luis R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; BONE MARROW TOXICITY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034891788     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2001.26345     Document Type: Article

References (25)

1. Antiphospholipid antibodies
2. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity
3. 2-glycoprotein I (apolipoprotein H)
4. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding
5. Antiphospholipid antibody syndrome
6. Antiphospholipid antibody syndrome
7. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 patients
8. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome
9. 2-glycoprotein I
10. 2-GPI
11. 2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
12. Endothelial cells as target for antiphospholipid antibodies
13. Vasculitis in the antiphospholipid syndrome: Culprit or consort?
14. The concomitant expression of vasculitis and coagulopathy: Synergy for marked tissue ischemia
15. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome
16. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: Association with severe vascular complications
17. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis
18. Lipoprotein (a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis
19. Anticardiolipin antibodies and giant cell arteritis: A prospective multicenter trial
20. Anticardiolipin antibodies and polyarteritis nodosa
21. Recurrent cerebral infarctions in polyarteritis nodosa with circulating antiphospholipid antibodies and mitral valve disease
22. Presence of anticardiolipin antibodies discriminates between Wegener's granulomatosis and microscopic polyarteritis
23. Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa
24. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis
25. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue - Infiltrating dendritic cells